Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
ASGCT’s Regulatory Affairs Committee Chair, Adora Ndu, PharmD, J.D., (pictured below at the Policy Summit) will serve as the ASGCT delegate to the USP Convention for a five-year cycle.
The United States Pharmacopeial (USP) Convention has invited ASGCT to join their organization as a voting member. Through membership in the USP Convention, ASGCT will have the opportunity to contribute its expertise to support the development of global health standards.
USP is an international organization with a mission to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. USP Convention members include more than 450 scientific, academic, patient, and industry associations, in addition to government agencies in the US and abroad. At the USP Convention meeting, which occurs every five years, delegates from voting members discuss USP’s next strategic plan and elect leadership and expert committees.
The chair of ASGCT’s Regulatory Affairs Committee, Adora Ndu, PharmD, J.D. will serve as the ASGCT delegate to the USP Convention for the five-year cycle. Dr. Ndu is the vice president of Regulatory Affairs; Policy, Research, Engagement (PRE) & International at BioMarin.
FDA photo
Credit: Daniel Soñé Photography, LLC
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico